Trending Keyword "pancreatic cancer"
“Pancreatic cancer” is trending because several high-profile, near-term updates have renewed public and clinical attention to new treatment options. On April 14, 2026, *Nature Medicine* published phase 2 results showing that elraglusib combined with standard chemotherapy improved outcomes in metastatic pancreatic ductal adenocarcinoma. Then on May 1, 2026, the U.S. FDA announced it issued a “safe to proceed” letter that allows expanded access (outside clinical trials) for daraxonrasib in previously treated metastatic PDAC. Given pancreatic cancer’s historically poor prognosis and limited effective options, these signals of potential survival benefit plus expanded-access pathways are strong drivers of searches right now. (nature.com)
Industries
Hospitals and oncology centers are a direct focus because expanded-access approvals and newly published trial results immediately affect clinical workflows (who gets offered which investigational regimen, and through what process).
Doctors & Specialists (medical oncologists/GI cancer teams) are tightly connected since patients and families search for pancreatic-cancer treatment eligibility, side effects, and “next-line” options when new trial outcomes appear and access pathways open.
Pharmaceuticals are directly connected because the current spike is tied to newly reported investigational drug data and regulatory access actions (e.g., elraglusib and daraxonrasib) that determine what candidates enter or expand development next.
Diagnostics are directly connected because modern pancreatic cancer treatment decisions increasingly depend on biomarkers and molecular profiling (e.g., staging/monitoring markers and tumor/genetic characteristics that influence targeted-therapy suitability).
Charities and health advocacy organizations are directly connected because major treatment headlines and perceived “breakthrough momentum” typically drive public awareness campaigns, donations, and caregiver/support inquiries around pancreatic cancer.
Keyword intents
Primarily a knowledge-seeking query about a disease (likely seeking definition, symptoms, causes, diagnosis, treatment, prognosis).
It denotes a serious health problem; users may be searching due to concern about symptoms, diagnosis, or risk.
Medical information can be time-sensitive (e.g., new treatments), but the keyword itself doesn’t imply "latest" or "2026".
It’s a short, broad term; could be expanded later into more specific long-tail questions, but the given keyword alone is not very specific.
The query is a general medical condition with no geographic modifier (no city/"near me"/location).
No buying/subscription/booking language (e.g., treatment centers, clinical trials signup, donate, buy).
Does not compare options (no "vs", "compare", "alternatives").
No seasonal/holiday/event cue tied to timing of the request.
No brand or specific website/product name included.
No company, organization, or drug/brand name referenced.
Not focused on a specific product, model, test kit, or therapy name.
No "how to" or self-treatment/instructions wording.
No mention of cost, pricing, insurance, or affordability.
No immediate timeframe cues like "now", "today", or emergency language.
Keyword ideas
Longtail
None stored yet.
Synonyms
None stored yet.
Antonyms
None stored yet.